Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGATTA: Uva Ursi vs Fosfomycin for Uncomplicated UTI
NCT03151603Phase 4Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- May 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of uva ursi in urinary tract infection (UTI) (2 arms), sponsored by Universitätsmedizin Göttingen. Primary endpoints: Number of antibiotic courses at 28 days and Symptom burden at 7 days. Started May 2017; status: completed.
02
Drugs
uva ursi
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03151603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151603.